CELESTE L AMAYA
Allopathic & Osteopathic Physicians|Internal Medicine NAPLES, FL NPI 1790718062
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine FL Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$479.40
- Category: General Payments
- Program years: PY2021–2022
- Record count: 20
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $198.89 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $198.89 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $134.87 | 4 |
| Amarin Pharma Inc. | $22.29 | 1 |
| Merck Sharp & Dohme Corporation | $14.77 | 1 |
| GlaxoSmithKline, LLC. | $14.38 | 1 |
| Amgen Inc. | $12.58 | 1 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 887365431 | Boehringer Ingelheim Pharmaceuticals, Inc. | $99.06 | 04/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 887705221 | Boehringer Ingelheim Pharmaceuticals, Inc. | $4.02 | 08/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 887705223 | Boehringer Ingelheim Pharmaceuticals, Inc. | $17.72 | 04/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 887705225 | Boehringer Ingelheim Pharmaceuticals, Inc. | $14.07 | 01/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 913948305 | Amarin Pharma Inc. | $22.29 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 939170561 | Amgen Inc. | $12.58 | 07/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 944295553 | Merck Sharp & Dohme LLC | $14.77 | 06/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 944376183 | GlaxoSmithKline, LLC. | $14.38 | 02/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.